OT: Nerds chatting [Bioanalytics]

posted by nobody – 2019-03-28 10:14 (705 d 01:12 ago) – Posting: # 20101
Views: 3,753

...and even worse (re Danish footer)

The FDA ordered AbbVie to stop recruiting multiple myeloma patients for a Phase III trial of its anti-cancer drug Venclexta/Venclyxto.

Forty-one out of 194 patients taking AbbVie’s Venclexta (venetoclax) in the company’s trial have died, the FDA found, nearly twice the percent of the patients in the trial’s placebo arm.

Kindest regards, nobody

Complete thread:

Activity
 Admin contact
21,358 posts in 4,459 threads, 1,492 registered users;
online 21 (0 registered, 21 guests [including 3 identified bots]).
Forum time: Tuesday 11:27 UTC (Europe/Vienna)

The interpretation of facts in a certain way
stimulates other scientists’ thoughts.    Róbert Bárány

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5